Proteomic profiling of the cancer cell secretome: informing clinical research

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Espert Review of Proteomics

• Publication date

  2017-08-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/14789450.2017.1353913PMID 28695748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins

  2016influential reference
• Identification of ganglioside GM2 activator playing a role in cancer cell migration through proteomic analysis of breast cancer secretomes

  2016cited by this paper
• Secretome profiling of oral squamous cell carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma

  2016cited by this paper
• Exosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis*

  2016influential reference
• Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.

  2016cited by this paper
• Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation

  2016cited by this paper
• Secretome protein signature of human pancreatic cancer stem-like cells.

  2016cited by this paper
• Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis

  2016cited by this paper
• Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway

  2016cited by this paper
• Identification of novel therapeutic targets in the secretome of ionizing radiation‑induced senescent tumor cells.

  2016cited by this paper
• An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.

  2016influential reference
• Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome

  2016cited by this paper
• Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer

  2016cited by this paper
• Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan

  2016cited by this paper
• A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer.

  2015cited by this paper
• Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance

  2015cited by this paper
• Glioblastoma-derived Macrophage Colony-stimulating Factor (MCSF) Induces Microglial Release of Insulin-like Growth Factor-binding Protein 1 (IGFBP1) to Promote Angiogenesis*

  2015cited by this paper
• Therapy-induced tumour secretomes promote resistance and tumour progression

  2015cited by this paper
• The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase

  2015cited by this paper
• Advances in high-resolution quantitative proteomics: implications for clinical applications

  2015cited by this paper
• Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients.

  2015cited by this paper
• Effect of cellular senescence on the growth of HER2-positive breast cancers.

  2015cited by this paper
• CCN1 Secreted by Tonsil‐Derived Mesenchymal Stem Cells Promotes Endothelial Cell Angiogenesis via Integrin αvβ3 and AMPK

  2015cited by this paper
• The Global Burden of Cancer 2013.

  2015cited by this paper
• Secretome Identifies Tenascin-X as a Potent Marker of Ovarian Cancer

  2015cited by this paper
• Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer.

  2015cited by this paper
• HCSD: the human cancer secretome database

  2015cited by this paper
• Current strategies and findings in clinically relevant post-translational modification-specific proteomics

  2015cited by this paper
• Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin

  2015cited by this paper
• Tissue-based map of the human proteome

  2015cited by this paper
• Identification of secreted proteins that reflect autophagy dynamics within tumor cells

  2015cited by this paper
• Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma

  2015cited by this paper
• Circulating pEGFR Is a Candidate Response Biomarker of Cetuximab Therapy in Colorectal Cancer

  2014cited by this paper
• Integrated Omic Analysis of Oropharyngeal Carcinomas Reveals Human Papillomavirus (HPV)–dependent Regulation of the Activator Protein 1 (AP-1) Pathway*

  2014cited by this paper
• Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion.

  2014cited by this paper
• Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth.

  2014cited by this paper
• Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.

  2014influential reference
• Phosphoprotein Secretome of Tumor Cells as a Source of Candidates for Breast Cancer Biomarkers in Plasma

  2014cited by this paper
• Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferation.

  2014cited by this paper
• Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.

  2014influential reference
• RLIP76 regulates HIF‐1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells

  2014cited by this paper
• SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations

  2014cited by this paper
• Applications and Comparisons of Four Time Series Models in Epidemiological Surveillance Data

  2014cited by this paper
• MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum

  2014cited by this paper
• Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma: Current State and Recent Advances

  2014cited by this paper
• Phase II Clinical and Exploratory Biomarker Study of Dacomitinib in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck

  2014cited by this paper
• In-depth proteomic delineation of the colorectal cancer exoproteome: Mechanistic insight and identification of potential biomarkers.

  2014cited by this paper
• Discovery of Specific Metastasis-Related N-Glycan Alterations in Epithelial Ovarian Cancer Based on Quantitative Glycomics

  2014cited by this paper
• Mass spectrometry based biomarker discovery, verification, and validation — Quality assurance and control of protein biomarker assays

  2014cited by this paper
• A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer

  2014cited by this paper
• Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma

  2013influential reference
• In-depth Characterization of the Secretome of Colorectal Cancer Metastatic Cells Identifies Key Proteins in Cell Adhesion, Migration, and Invasion*

  2013influential reference
• Epithelial ovarian cancer-induced angiogenic phenotype of human omental microvascular endothelial cells may occur independently of VEGF signaling.

  2013cited by this paper
• A Blood-Based Proteomic Classifier for the Molecular Characterization of Pulmonary Nodules

  2013cited by this paper
• Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes

  2013cited by this paper
• In Vivo DPP-4 Inhibition to Enhance Engraftment of Single-Unit Cord Blood Transplants in Adults with Hematological Malignancies

  2013cited by this paper
• The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.

  2013cited by this paper
• Finding the right antibody for the job

  2013cited by this paper
• Low-molecular-mass secretome profiling identifies C-C motif chemokine 5 as a potential plasma biomarker and therapeutic target for nasopharyngeal carcinoma.

  2013cited by this paper
• Comparative Secretome Analysis of Epithelial and Mesenchymal Subpopulations of Head and Neck Squamous Cell Carcinoma Identifies S100A4 as a Potential Therapeutic Target*

  2013cited by this paper
• Potentially Novel Candidate Biomarkers for Head and Neck Squamous Cell Carcinoma Identified Using an Integrated Cell Line-based Discovery Strategy*

  2012influential reference
• Identification of EFEMP2 as a serum biomarker for the early detection of colorectal cancer with lectin affinity capture assisted secretome analysis of cultured fresh tissues.

  2012cited by this paper
• Comparative secretome analyses using a hollow fiber culture system with label-free quantitative proteomics indicates the influence of PARK7 on cell proliferation and migration/invasion in lung adenocarcinoma.

  2012cited by this paper
• Secretome analysis of ionizing radiation‐induced senescent cancer cells reveals that secreted RKIP plays a critical role in neighboring cell migration

  2012cited by this paper
• Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance

  2012cited by this paper
• Analytical constraints for the analysis of human cell line secretomes by shotgun proteomics.

  2012cited by this paper
• Comparison of three different enrichment strategies for serum low molecular weight protein identification using shotgun proteomics approach.

  2012cited by this paper
• Selective enrichment of newly synthesized proteins for quantitative secretome analysis

  2012cited by this paper
• Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness

  2012cited by this paper
• Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers.

  2012cited by this paper
• Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer.

  2012cited by this paper
• Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead

  2011cited by this paper
• SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.

  2011cited by this paper
• Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis.

  2011cited by this paper
• Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome

  2011cited by this paper
• Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection

  2011cited by this paper
• Soluble E‐cadherin as a serum biomarker candidate: Elevated levels in patients with late‐stage colorectal carcinoma and FAP

  2011influential reference
• A targeted proteomics–based pipeline for verification of biomarkers in plasma

  2011cited by this paper
• Discovery of IL-18 As a Novel Secreted Protein Contributing to Doxorubicin Resistance by Comparative Secretome Analysis of MCF-7 and MCF-7/Dox

  2011cited by this paper
• Importin subunit alpha‐2 is identified as a potential biomarker for non‐small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome

  2011cited by this paper
• Proteomic Identification of Betaig-h3 as a Lysophosphatidic Acid-Induced Secreted Protein of Human Mesenchymal Stem Cells: Paracrine Activation of A549 Lung Adenocarcinoma Cells by Betaig-h3*

  2011cited by this paper
• Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer Biomarkers

  2011cited by this paper
• Transforming growth factor‐beta‐induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells

  2011cited by this paper
• A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer.

  2011cited by this paper
• On the development of plasma protein biomarkers.

  2011cited by this paper
• Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: Potential usage of cystatin A for predicting nodal stage and poor prognosis

  2010cited by this paper
• Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum.

  2010cited by this paper
• Candidate Serological Biomarkers for Cancer Identified from the Secretomes of 23 Cancer Cell Lines and the Human Protein Atlas*

  2010cited by this paper
• Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome

  2010cited by this paper
• Secretome-based identification and characterization of potential biomarkers in thyroid cancer.

  2010cited by this paper
• Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.

  2010cited by this paper
• The cancer cell secretome: a good source for discovering biomarkers?

  2010cited by this paper
• Secretome proteomics for discovery of cancer biomarkers.

  2010cited by this paper
• Up‐regulated Proteins in the Fluid Bathing the Tumour Cell Microenvironment as Potential Serological Markers for Early Detection of Cancer of the Breast

  2010cited by this paper
• A centrifugal ultrafiltration strategy for isolating the low-molecular weight (<or=25K) component of human plasma proteome.

  2010cited by this paper
• Identification of Five Candidate Lung Cancer Biomarkers by Proteomics Analysis of Conditioned Media of Four Lung Cancer Cell Lines*

  2009cited by this paper
• Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.

  2009cited by this paper
• An Enhanced Mass Spectrometry Approach Reveals Human Embryonic Stem Cell Growth Factors in Culture*S

  2009cited by this paper

• Characterizing the secretome of EGFR mutant lung adenocarcinoma

  2024cites this paper
• 信号识别颗粒14调控肝细胞癌进程并影响患者预后

  2024cites this paper
• Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib

  2023cites this paper
• Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps

  2023cites this paper
• Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models

  2023cites this paper
• Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications

  2022cites this paper
• Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC

  2021cites this paper
• Pattern-recognition-based Sensor Arrays for Cell Characterization: From Materials and Data Analyses to Biomedical Applications

  2020cites this paper
• An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Gliome database: a comprehensive web-based tool to access and analyze glia secretome data

  2020cites this paper
• Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic review

  2020cites this paper
• Liquid Biopsy in der Tumordiagnostik

  2019cites this paper
• Liquid Biopsy in der Tumordiagnostik . Anwendungen , Perspektiven und Limitationen des Cancer Liquidome

  2019cites this paper
• Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells

  2019cites this paper
• Tumor Transcriptome Reveals High Expression of IL-8 in Non-Small Cell Lung Cancer Patients with Low Pectoralis Muscle Area and Reduced Survival

  2019cites this paper
• Prediction of lymph node metastasis in oral squamous cell carcinoma based on protein profile

  2019cites this paper
• Tumor Transcriptome in Patients with Lower Pectoralis Muscle Area Reveals IL-8 as a Prognostic Biomarker in Non-Small Cell Lung Cancer

  2019cites this paper
• University of Southern Denmark Tumor transcriptome reveals high expression of IL-8 in non-small cell lung cancer patients with low pectoralis muscle area and reduced survival Cury,

  2019cites this paper
• Metal-Organic Framework Nanoparticle-Based Biomineralization: A New Strategy toward Cancer Treatment

  2019cites this paper
• Liquid Biopsy in der Tumordiagnostik

  2019cites this paper
• Biomarkers: Delivering on the expectation of molecularly driven, quantitative health

  2018cites this paper
• Proteomic Characterization of Plasma Cells from Patients with Multiple Myeloma

  2018cites this paper
• Integrated omics profiling identifies hypoxia-regulated genes in HCT116 colon cancer cells.

  2018cites this paper
• New target proteins for drug discovery in colon cancer

  2018cites this paper